【摘要】 目的探索抑制乙肝病毒复制,治疗慢性乙型肝炎安全有效的治疗方法。方法采取随机分组,2组对比的方法。抽取空腹血化验肝功能、乙肝病毒标志物及乙肝病毒复制指标,用卡方检验。结果治疗组ALT、TBIL复常率及HBV-DNA转阴率高于对照组,但差异无显著性意义(P>0.05);治疗组总有效率高于对照组(P<0.05)。结论胸腺肽联合阿德福韦酯是抑制乙肝病毒复制、治疗慢性乙型肝炎安全有效的方法。

    【关键词】 慢性乙型肝炎 胸腺肽 阿德福韦酯

    【中图分类号】 R4【文献标识码】 A【文章编号】 1674-0742(2011)03(a)-0110-01

    【Abstract】 ObjectiveTo explore the safe and effective treatment to inhibit hepatitis B virus replication and treat chronic hepatitis B.MethodsA randomized comparison of two.Get fasting blood liver function tests,hepatitis B virus markers and hepatitis B virus replication index and then test with chi-square.ResultsThe ALT,TBIL’s recovery rate and HBV-DNA negative rate is higher than the control group,but the difference was not significant(P>0.05);the efficiency of the treatment group was higher than the control group(P<0.05).ConclusionAdefovir dipivoxil Thymosin hepatitis B virus replication is safe and effective method to inhibit hepatitis B virus replication and treat chronic hepatitis B. ......